Pfizer | Business Post

Pfizer warned government that low drug budget will delay access to new medicines

The pharma giant, which employs around 4,000 people here, said Ireland was 24th out of 35 countries for the availability of new medicines

Cost of AstraZeneca’s next-gen Dublin project may top €600m

Manufacturing facility likely to be much larger than initially planned

Pfizer chief: €1.2 billion Irish investment is just the start

Mike McDermott, chief global supply officer and executive vice-president, says Pfizer will continue to invest in its Irish operations beyond the major Grange Castle investment announced last week

Carrick Therapeutics lands $35m investment from Pfizer

Dublin-based biopharma firm has received investment to support the rapid development of its flagship drug samuraciclib which is used in the treatment of HR+, HER2- breast cancer

Up to 500 jobs to be created at Pfizer’s new ‘state of the art’ Dublin plant

The company will invest €1.2 billion in the facility, which is expected to be completed by 2027

Eli Lilly’s investment in new biopharma plant will be at least €1.2 billion

Amount that US pharma giant is investing in Limerick facility is much more than originally thought, as scale and fit-out of campus emerges

Today's headlines

Pfizer to invest €1bn in new Dublin plant; Irish government hopes for Sunak as next UK PM

The top stories from business and politics in today’s Business Post

Exclusive: Pfizer to invest €1 billion in new Dublin biotech plant

The company, which already employs 4,000 people in Ireland, is understood to be at an advanced stage in its plans for the facility which would be one of the largest pharmaceutical investments in the history of the state

Pfizer warned government over changes to corporate tax

Pharmaceutical giant said elements of the plan to overhaul tax rules would create ‘winners and losers’

DPS €295m deal will be ‘game changer’ for engineering services sector

Dutch company Arcadis’s purchase of the Dublin-based firm will give it a new global reach, say industry sources

New Pfizer antivirals could be available on wider market in future

The new Paxlovid pills currently for ‘high-risk’ patients only will become available in Ireland in the coming weeks

Covid-19 antiviral pills may not be available in Ireland till end of next month

The pills can be taken at home and are similar to an antibiotic, but are in short supply globally

Government seeks to get Paxlovid before other EU countries

Pfizer anti-viral pill cuts risk of hospitalisation and death from Covid-19 dramatically

Pfizer’s Paxlovid pill given emergency go-ahead by Europe’s medicines watchdog

The EMA has issued advice ‘to support national authorities who may decide on possible early use of the medicine prior to marketing authorisation’

Delta-specific vaccine could be ready in time for winter booster campaign

Pfizer will begin clinical trials next month for an altered version of its Covid jab that targets full spike protein of variant

Sunday Interview: Paul Reid of Pfizer Healthcare Ireland

The country manager on the development of the pioneering vaccine and why Ireland will not be used as a manufacturing base for it in the short term

Comment: Vaccination numbers don’t add up – we’ll be living and dying with Covid-19 until 2022

Ireland needs to be vaccinating upwards of 100,000 people a week but we show no signs of getting close to that figure

Pfizer vaccine approved by EMA

Ireland to receive 5,000 doses by the end of the year, nursing home residents over 65 first in line to be vaccinated

Vaccine trials were run to the highest regulatory standards says Icon drug trials leader

Dr Nuala Murphy, president of clinical research at the Dublin HQ of drug testing giant Icon says she will be ‘absolutely’ taking the Pfizer/BioNtech vaccine

BioNtech in bid to increase vaccine production by 750 million doses a year

Covid-19 vaccine co-manufacturer buys new manufacturing plant from Novartis in Germany to ramp up production